Get started
Author

José Carlos Barros

Observed names: Jose C. Barros, Jose Carlos Barros, Jose Carlos de Almeida Barros, José C. Barros, José Carlos Barros, José C. Barros, José Carlos de Almeida Barros, José Carlos de Barros
Observed institutions: Irmandade da Santa Casa de Misericórdia de São Paulo, Hospital Alemão Oswaldo Cruz, São Camilo Hospital, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Dr. Euryclides Hospital de Jesus Zerbini, Hospital Sírio-Libanês
OpenAlex ID: A5111681908
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma
2012 · Angelo Maiolino, Vania T.M. Hungria, et al. · American Journal of Hematology · 59
Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis
2010 · Paulo Sérgio da Silva Santos, Fábio Luiz Coracin, et al. · Clinical Transplantation · 41
Peripheral blood stem cell yield calculated using preapheresis absolute CD 34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers
2013 · Chitra Hosing, Rima M. Saliba, et al. · Transfusion · 34
Assessment of Labile Plasma Iron in Patients Who Undergo Hematopoietic Stem Cell Transplantation
2013 · Flávio Augusto Naoum, Breno Pannia Espósito, et al. · Acta Haematologica · 25
Survival and graft‐versus‐host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA ‐matched related donor: retrospective analysis of 334 consecutive patients
2015 · Paulo Vidal Campregher, Nelson Hamerschlak, et al. · European Journal Of Haematology · 19
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients.
2011 · Leina Y Etto, Vânia Maris Morelli, et al. · PubMed Central · 16
Targeted‐dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial
2020 · Iracema Esteves, Fabio Pires Souza Santos, et al. · Hematological Oncology · 12
Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
2014 · Edvan de Queiroz Crusoe, Fabiana Higashi, et al. · Revista Brasileira de Hematologia e Hemoterapia · 11
PDF
Desafios do acesso a medicamentos no Brasil
2020 · Eduardo Chaves Leal, José Carlos Barros, et al. · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 10
Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus
2014 · Paulo Sérgio da Silva Santos, Fábio Luiz Coracin, et al. · Einstein (São Paulo) · 9
PDF
Perfil microbiológico dos pacientes nos primeiros trinta dias pós transplante de medula óssea do Serviço de Transplantes da Santa Casa de São Paulo
2002 · Flávio A. Naoum, Larissa T. V. Martins, et al. · Revista Brasileira de Hematologia e Hemoterapia · 8
PDF
Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population
2016 · Clarissa Vasconcellos de Souza, Afonso Celso Vigorito, et al. · Transplantation and Cellular Therapy · 7
PDF
Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
2016 · Edvan de Queiroz Crusoe, Fabiana Higashi, et al. · Revista Brasileira de Hematologia e Hemoterapia · 5
PDF
Assessmet of Labile Plasma Iron and Hepcidin in Patients Who Undergo Hematopoietic Stem Cell Transplantation
2014 · Flávio Augusto Naoum, Breno Pannia Esposito, et al. · Blood · 2
Leucemia linfocítica crônica & visão geral
2009 · José Carlos Barros · Revista Brasileira de Hematologia e Hemoterapia · 2
PDF
The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan
2014 · Iracema Esteves, Juliana F Fernandes, et al. · Blood · 1
Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma: the DD Protocol
2005 · Frederico Luiz Dulley, Rosaura Saboya, et al. · Sao Paulo Medical Journal · 1
PDF
Autologous Stem Cell Transplantation for the Treatment of Pediatric Solid Tumors in Brazil
2005 · Cláudio Galvão de Castro Junior, Wellington Mendes, et al. · Journal of Pediatric Hematology/Oncology · 1
Hsct for Chronic Lymphocytic Leukemia
2021 · Carlos Chiattone, Vinicius Campos de Molla, et al. · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
PDF
Author response for "Targeted‐dose of busulfan: higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol.min. A historically‐controlled clinical trial"
2020 · Iracema Esteves, Fabio Pires Souza Santos, et al. · Publons reviews and discussion
Author response for "Targeted‐dose of busulfan: higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol.min. A historically‐controlled clinical trial"
2020 · Iracema Esteves, Fabio Pires Souza Santos, et al. · Publons reviews and discussion
Impact of Labile Plasma Iron on Viability of Cultured Mononuclear Cells
2014 · Flavio Augusto Naoum, Idiberto José Zotarelli, et al. · Blood
Contents Vol. 131, No. 4, 2014
2014 · Naadira Vanker, Hayley Ipp, et al. · Acta Haematologica
PDF
Front & Back Matter
2014 · Naadira Vanker, Hayley Ipp, et al. · Acta Haematologica
Lack Of Advantage Of Peripheral Blood Hematopoietic Stem Cell Transplantation Over Bone Marrow From HLA Matched Related Donors After Myeloablative Conditioning For Hematologic Malignancies
2013 · Paulo Vidal Campregher, Nelson Hamerschlak, et al. · Blood
Works count: 34
Citation count: 263
H-index: 9
I10-index: 9
Year
Topic
Type